Answers are grounded in this paper and cite their sources.
High Resolution Image Download MS PowerPoint Slide Enantioenriched sulfinamides serve as key intermediates for the asymmetric synthesis of sulfoximines and other S(VI) pharmacophores. Enantioselective biocatalytic oxidation of an S -methyl sulfenamide to the corresponding S -methyl sulfinamide proceeds in good yield and >99:1 er. Its utility as a key chiral intermediate was demonstrated by stereoretentive S -arylation and S -alkylation as well as by the asymmetric synthesis of two S -methyl sulfoximine drug candidates, with S -methyl substitution notably present in most sulfoximine clinical candidates.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: